This is supported by the patient database analysis conducted by Fei et al. [24], who suggested that EGR4 may be a potential oncogene in breast cancer after showing that the upregulation of EGR4 is correlated with breast cancer grade. The gene discussed is EGR4; the disease is breast carcinoma.